# Neurescue

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neurescue-aps

- Industry: Medical Devices & Equipment
- Headquarters: Copenhagen, Denmark
- Website: www.neurescue.com
- Total disclosed funding: $11M
- Latest round: Series A (Feb 5, 2024)
- Investors on record: 3

## About

Based in Copenhagen, Denmark, and founded in 2014 by CEO Habib Frost and Bjorn Broby Glavind, Neurescue Aps, a.k.a. Neurescue operates as a medical device company focused on advancing the treatment of cardiac arrest, the leading cause of death worldwide. In February 2024, Neurescue Aps raised DKK 50 million in a Series A funding led by West Hill Capital. In addition, Neurescue Aps also raised venture funding from Nina Capital.

The company's flagship product, the Neurescue device, is an intelligent fluoroscopy-free aortic balloon catheter, designed to enhance patient outcomes during life-threatening emergencies. The Neurescue device works by inflating a balloon in the descending aorta via a femoral artery introducer sheath.

The company plans to use its proceeds from February 2024 funding to expand its business in the emergency medical device market.

## Funding rounds

- Series A, Feb 5, 2024, $7.2M — West Hill Capital
- Series A, Apr 6, 2017, $3.7M — SEED Capital, GreenOcean Capital

## Investors

- SEED Capital (https://capitalatlas.ai/funds/seed-capital) — Series A
- GreenOcean Capital — Series A
- West Hill Capital (https://capitalatlas.ai/funds/west-hill-capital) — Series A